News about ISCIII

Institutional April 2 2025

Hospital Clínic-IDIBAPS, pioneer in CAR T-cell therapies for cancer with over 500 patients treated

Hospital Clínic-IDIBAPS is the only hospital in Europe to have fully developed two academic CAR T-cell therapies that have been approved by a regul...

Research March 28 2025

Colonoscopy and faecal occult blood tests are equivalent in detecting colorectal cancer

Researchers at IDIBAPS-Hospital Clínic and Hospital Universitario de Canarias have coordinated a study involving 57,000 people that compares the ef...

Institutional July 8 2024

IDIBAPS, newly reaccredited as an institute for health research by the Carlos III Health Institute

IDIBAPS successfully and positively achieved its first reaccreditation in 2014, and its second in 2019. 

Research December 17 2021

Hospital Clínic-IDIBAPS has developed a CAR-T cell therapy for multiple myeloma that shows an effectiveness of over 70% after one-year follow-up

The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood ca...